Bone is one of the few organs capable of regeneration after a substantial injury. As the bone heals itself after trauma, the coupling of angiogenesis to osteogenesis is crucial for the restoration of the skeletal tissue. In prior studies we have shown that Bone Morphogenetic Protein 2 (BMP2), a potent agonist for skeletal formation is expressed by vessels making it a prime candidate that links the morphogenesis of the two tissues. To investigate the role of BMP2 in the coordination of vessel and bone formation, we used a tamoxifen inducible Smooth Muscle Actin (SMA) promoter that conditionally expresses Cre recombinases crossed with a BMP2 floxed mouse in order to conditionally delete the BMP2 gene in smooth muscle actin (SMA) expressing cells. Using the mouse femur as our model for bone regeneration, we performed a surgical technique called distraction osteogenesis (DO) where an osteotomy is created followed by distraction or a gradual separation of the two pieces of bone. This primarily promotes intramembranous ossification at the osteotomy site by mechanical stimulation. Tamoxifen treatment started at day 6 and continued throughout the experiment. At post-operative days 3, 7, 12, 17, 24, and 31, we analyzed the bone and vessel formation by plain X-ray, micro-computed tomography (µCT) and vascular contrast enhanced µCT, and quantitative polymerase chain reaction (qPCR) of selective genes. We assessed both the femur and surrounding tissue to obtain qualitative and quantitative assessments for skeletal and vascular formation. Our results demonstrated that the deletion of BMP2 in vascular tissue resulted in a reduction of angiogenesis in vivo followed by a decrease in skeletal tissue development.

Introdução: A apneia do sono causa hipóxia intermitente (HI), que tem sido implicada na resistência à insulina. A proteína desacopladora 2 (UCP2) no pâncreas é reguladora negativa da secreção de insulina. Objetivos do Estudo: Avaliar se a exposição animal ao modelo de apneia do sono influencia na produção de insulina via expressão do mRNA da UCP2. Desenho e intervenções: Camundongos C57BL machos foram expostos durante 35 dias à hipóxia intermitente (HI; n = 18) ou HI simulada (HIS; n = 18). Durante 8 horas diárias o grupo HI foi submetido a um total de 480 ciclos de 30 segundos de hipóxia progressiva a um nadir da fração inspirada de oxigênio de 8 ± 1%, seguido por 30 segundos de normóxia. Métodos e Resultados: A expressão do mRNA da UCP-2 no pâncreas, avaliada por PCR em tempo real, foi 18% mais baixa no grupo HI do que no grupo HIS (P = 0,14). Imunohistoquímica identificou maior número de células beta no grupo HI do que no HIS (P = 0,14). Os níveis de glicose no soro medidos por métodos colorimétricos enzimáticos foram menores no grupo HI do que no grupo HIS (P = 0,025). Níveis significativamente maiores de insulina no soro, quantificados por ELISA, e níveis significativamente mais baixos de glucagon, quantificados por EIA, foram observados no grupo HI, quando comparado ao grupo HIS. Os cálculos do modelo de avaliação da homeostase (HOMA) para a resistência à insulina sugerem maior sensibilidade em HI do que em camundongos HIS (P = 0,09). A função das células beta, avaliada por HOMA - β foi maior em camundongos HI do que nos HIS (P = 0,014). O peso corporal, ajustado ao consumo alimentar, foi relativamente estável durante o experimento. Não foram encontradas diferenças significativas no perfil lipídico. Conclusões: Estes resultados sugerem que a HI provoca alterações na função pancreática que não podem ser relacionadas com a expressão do mRNA da UCP2. / Background: Sleep apnea causes intermittent hypoxia (IH) that has been implicated in insulin resistance. Pancreatic uncoupling protein-2 (UCP2) is a negative regulator of insulin secretion. Study Objectives: To evaluate whether exposure to an animal model of sleep apnea influences insulin output via UCP2 expression. Design and interventions: Male C57BL mice were exposed during 35 days to intermittent hypoxia (IH; n=18) or to sham IH (SIH; n=18). During 8 hours daily the IH group underwent a total of 480 cycles of 30 seconds of progressive hypoxia to a nadir FIO2 of 8±1% followed by 30 seconds of normoxia. Measurements and Results: The expression of pancreatic UCP-2 mRNA assessed by real-time PCR was 18% lower (P=0.14) in the IH than in the SIH group. Immunohistochemistry identified higher number of beta cells in IH than in SIH group (P=0.14). Glucose levels measured in serum by enzymatic colorimetric methods was lower in IH than in SIH group (P=0.025). Significantly higher serum insulin quantified by ELISA and lower glucagon levels quantified by EIA were seen in the IH group when compared with SIH. Calculations of homeostasis model assessment (HOMA) for insulin resistance suggest higher sensitivity in IH than in SIH mice (P=0.09). HOMA for beta-cell function was higher in IH than in SIH mice (P=0.014). Body weight, adjusted for food intake, was relatively stable during the experiment. No significant differences in lipid profile were encountered. Conclusions: These results suggest that IH causes changes in pancreatic function that may be not related to expression of mRNA UCP2.

Muitas espécies de pimentas vermelhas do gênero Capsicum são utilizadas em práticas medicinais tradicionais. Essas plantas são empregadas em algumas preparações para tratar uma variedade de doenças, incluindo infecções. Algumas bactérias produzem biofilme como um importante fator de virulência, pois a estrutura do biofilme intermedia a adesão bacteriana a superfícies, como em dispositivos implantados, sondas e cateteres além de promover proteção física contra os antibióticos ou as respostas do sistema imunológico. Dessa maneira, este estudo investigou a capacidade do extrato e de produtos isolados das sementes de Capsicum baccatum como agentes antibiofilme. Este estudo demonstra, pela primeira vez, que um extrato de C. baccatum apresentou importante atividade antibiofilme contra Staphylococcus epidermidis e Pseudomonas aeruginosa. A fração ativa foi obtida através de ensaios bioguiados e analisada por HPLC-DAD-MS, MALDI-TOF MS e MALDI-MS/MS, identificando-a como peptídeos da proteína 2S sulfur-rich seed storage protein 2-like. Estes peptídeos (2mg/ml) foram potentes no controle da formação de biofilme de S. epidermidis (>96%) em solução e adsorvidos em lâminas de Permanox® recobertas. De modo interessante, não inibiram o crescimento bacteriano, indicando que a inibição do biofilme é independente da morte celular bacteriana. Ainda, esses peptídeos foram capazes de preservar eritrócitos, bem como a integridade de linfócitos humanos após 24 e 48 horas de exposição, demonstrando que o fracionamento do extrato de C. baccatum potencializou a sua atividade antibiofilme e reduziu significativamente a sua citotoxicidade. Nossos resultados corroboram com a pesquisa de novas estratégias não antibióticas para combater microrganismos com reduzida possibilidade para o desenvolvimento de resistência. / Many species of Capsicum red peppers are used in traditional medicinal practices. These plants are utilized in a number of preparations to treat a variety of illnesses including infections. Some bacteria produce biofilm as an important virulence factor, due to this its structure mediates the adhesion to surfaces as implanted devices, probes, catheters and also promotes physical protection against the antibiotics or the immune system response. Accordingly, this study investigated the ability of the extract and isolated products from seeds of Capsicum baccatum as anti-biofilm agent. This study demonstrates by the first time that an extract from C. baccatum presented relevant anti-biofilm activity against Staphylococcus epidermidis and Pseudomonas aeruginosa. The active fraction was obtained by bio-guided assays and analyzed by HPLC-DAD-MS, MALDI-TOF MS and MALDI-MS/MS, identifying it as peptides from 2S sulfur-rich seed storage protein 2-like. It strongly controlled (2mg/ml) the S. epidermidis biofilm formation (>96%) when the compound was in solution and adsorbed on Permanox™ slides. Interestingly, it did not inhibit the growth of this bacterium, indicating the inhibition of biofilm is independent of bacterial cell death. Moreover, this peptides preserved human erythrocytes and lymphocytes integrity after 24-48 h of exposure, suggesting the fractionation potentiated the anti-biofilm activity of the C. baccatum crude extract while absolutely reduced its cytotoxicity. Our results corroborate to the search of new non-antibiotic strategies to combat microorganisms with a reduced pressure for resistance development.

Muitas espécies de pimentas vermelhas do gênero Capsicum são utilizadas em práticas medicinais tradicionais. Essas plantas são empregadas em algumas preparações para tratar uma variedade de doenças, incluindo infecções. Algumas bactérias produzem biofilme como um importante fator de virulência, pois a estrutura do biofilme intermedia a adesão bacteriana a superfícies, como em dispositivos implantados, sondas e cateteres além de promover proteção física contra os antibióticos ou as respostas do sistema imunológico. Dessa maneira, este estudo investigou a capacidade do extrato e de produtos isolados das sementes de Capsicum baccatum como agentes antibiofilme. Este estudo demonstra, pela primeira vez, que um extrato de C. baccatum apresentou importante atividade antibiofilme contra Staphylococcus epidermidis e Pseudomonas aeruginosa. A fração ativa foi obtida através de ensaios bioguiados e analisada por HPLC-DAD-MS, MALDI-TOF MS e MALDI-MS/MS, identificando-a como peptídeos da proteína 2S sulfur-rich seed storage protein 2-like. Estes peptídeos (2mg/ml) foram potentes no controle da formação de biofilme de S. epidermidis (>96%) em solução e adsorvidos em lâminas de Permanox® recobertas. De modo interessante, não inibiram o crescimento bacteriano, indicando que a inibição do biofilme é independente da morte celular bacteriana. Ainda, esses peptídeos foram capazes de preservar eritrócitos, bem como a integridade de linfócitos humanos após 24 e 48 horas de exposição, demonstrando que o fracionamento do extrato de C. baccatum potencializou a sua atividade antibiofilme e reduziu significativamente a sua citotoxicidade. Nossos resultados corroboram com a pesquisa de novas estratégias não antibióticas para combater microrganismos com reduzida possibilidade para o desenvolvimento de resistência. / Many species of Capsicum red peppers are used in traditional medicinal practices. These plants are utilized in a number of preparations to treat a variety of illnesses including infections. Some bacteria produce biofilm as an important virulence factor, due to this its structure mediates the adhesion to surfaces as implanted devices, probes, catheters and also promotes physical protection against the antibiotics or the immune system response. Accordingly, this study investigated the ability of the extract and isolated products from seeds of Capsicum baccatum as anti-biofilm agent. This study demonstrates by the first time that an extract from C. baccatum presented relevant anti-biofilm activity against Staphylococcus epidermidis and Pseudomonas aeruginosa. The active fraction was obtained by bio-guided assays and analyzed by HPLC-DAD-MS, MALDI-TOF MS and MALDI-MS/MS, identifying it as peptides from 2S sulfur-rich seed storage protein 2-like. It strongly controlled (2mg/ml) the S. epidermidis biofilm formation (>96%) when the compound was in solution and adsorbed on Permanox™ slides. Interestingly, it did not inhibit the growth of this bacterium, indicating the inhibition of biofilm is independent of bacterial cell death. Moreover, this peptides preserved human erythrocytes and lymphocytes integrity after 24-48 h of exposure, suggesting the fractionation potentiated the anti-biofilm activity of the C. baccatum crude extract while absolutely reduced its cytotoxicity. Our results corroborate to the search of new non-antibiotic strategies to combat microorganisms with a reduced pressure for resistance development.

Introdução: A apneia do sono causa hipóxia intermitente (HI), que tem sido implicada na resistência à insulina. A proteína desacopladora 2 (UCP2) no pâncreas é reguladora negativa da secreção de insulina. Objetivos do Estudo: Avaliar se a exposição animal ao modelo de apneia do sono influencia na produção de insulina via expressão do mRNA da UCP2. Desenho e intervenções: Camundongos C57BL machos foram expostos durante 35 dias à hipóxia intermitente (HI; n = 18) ou HI simulada (HIS; n = 18). Durante 8 horas diárias o grupo HI foi submetido a um total de 480 ciclos de 30 segundos de hipóxia progressiva a um nadir da fração inspirada de oxigênio de 8 ± 1%, seguido por 30 segundos de normóxia. Métodos e Resultados: A expressão do mRNA da UCP-2 no pâncreas, avaliada por PCR em tempo real, foi 18% mais baixa no grupo HI do que no grupo HIS (P = 0,14). Imunohistoquímica identificou maior número de células beta no grupo HI do que no HIS (P = 0,14). Os níveis de glicose no soro medidos por métodos colorimétricos enzimáticos foram menores no grupo HI do que no grupo HIS (P = 0,025). Níveis significativamente maiores de insulina no soro, quantificados por ELISA, e níveis significativamente mais baixos de glucagon, quantificados por EIA, foram observados no grupo HI, quando comparado ao grupo HIS. Os cálculos do modelo de avaliação da homeostase (HOMA) para a resistência à insulina sugerem maior sensibilidade em HI do que em camundongos HIS (P = 0,09). A função das células beta, avaliada por HOMA - β foi maior em camundongos HI do que nos HIS (P = 0,014). O peso corporal, ajustado ao consumo alimentar, foi relativamente estável durante o experimento. Não foram encontradas diferenças significativas no perfil lipídico. Conclusões: Estes resultados sugerem que a HI provoca alterações na função pancreática que não podem ser relacionadas com a expressão do mRNA da UCP2. / Background: Sleep apnea causes intermittent hypoxia (IH) that has been implicated in insulin resistance. Pancreatic uncoupling protein-2 (UCP2) is a negative regulator of insulin secretion. Study Objectives: To evaluate whether exposure to an animal model of sleep apnea influences insulin output via UCP2 expression. Design and interventions: Male C57BL mice were exposed during 35 days to intermittent hypoxia (IH; n=18) or to sham IH (SIH; n=18). During 8 hours daily the IH group underwent a total of 480 cycles of 30 seconds of progressive hypoxia to a nadir FIO2 of 8±1% followed by 30 seconds of normoxia. Measurements and Results: The expression of pancreatic UCP-2 mRNA assessed by real-time PCR was 18% lower (P=0.14) in the IH than in the SIH group. Immunohistochemistry identified higher number of beta cells in IH than in SIH group (P=0.14). Glucose levels measured in serum by enzymatic colorimetric methods was lower in IH than in SIH group (P=0.025). Significantly higher serum insulin quantified by ELISA and lower glucagon levels quantified by EIA were seen in the IH group when compared with SIH. Calculations of homeostasis model assessment (HOMA) for insulin resistance suggest higher sensitivity in IH than in SIH mice (P=0.09). HOMA for beta-cell function was higher in IH than in SIH mice (P=0.014). Body weight, adjusted for food intake, was relatively stable during the experiment. No significant differences in lipid profile were encountered. Conclusions: These results suggest that IH causes changes in pancreatic function that may be not related to expression of mRNA UCP2.

Introdução: A apneia do sono causa hipóxia intermitente (HI), que tem sido implicada na resistência à insulina. A proteína desacopladora 2 (UCP2) no pâncreas é reguladora negativa da secreção de insulina. Objetivos do Estudo: Avaliar se a exposição animal ao modelo de apneia do sono influencia na produção de insulina via expressão do mRNA da UCP2. Desenho e intervenções: Camundongos C57BL machos foram expostos durante 35 dias à hipóxia intermitente (HI; n = 18) ou HI simulada (HIS; n = 18). Durante 8 horas diárias o grupo HI foi submetido a um total de 480 ciclos de 30 segundos de hipóxia progressiva a um nadir da fração inspirada de oxigênio de 8 ± 1%, seguido por 30 segundos de normóxia. Métodos e Resultados: A expressão do mRNA da UCP-2 no pâncreas, avaliada por PCR em tempo real, foi 18% mais baixa no grupo HI do que no grupo HIS (P = 0,14). Imunohistoquímica identificou maior número de células beta no grupo HI do que no HIS (P = 0,14). Os níveis de glicose no soro medidos por métodos colorimétricos enzimáticos foram menores no grupo HI do que no grupo HIS (P = 0,025). Níveis significativamente maiores de insulina no soro, quantificados por ELISA, e níveis significativamente mais baixos de glucagon, quantificados por EIA, foram observados no grupo HI, quando comparado ao grupo HIS. Os cálculos do modelo de avaliação da homeostase (HOMA) para a resistência à insulina sugerem maior sensibilidade em HI do que em camundongos HIS (P = 0,09). A função das células beta, avaliada por HOMA - β foi maior em camundongos HI do que nos HIS (P = 0,014). O peso corporal, ajustado ao consumo alimentar, foi relativamente estável durante o experimento. Não foram encontradas diferenças significativas no perfil lipídico. Conclusões: Estes resultados sugerem que a HI provoca alterações na função pancreática que não podem ser relacionadas com a expressão do mRNA da UCP2. / Background: Sleep apnea causes intermittent hypoxia (IH) that has been implicated in insulin resistance. Pancreatic uncoupling protein-2 (UCP2) is a negative regulator of insulin secretion. Study Objectives: To evaluate whether exposure to an animal model of sleep apnea influences insulin output via UCP2 expression. Design and interventions: Male C57BL mice were exposed during 35 days to intermittent hypoxia (IH; n=18) or to sham IH (SIH; n=18). During 8 hours daily the IH group underwent a total of 480 cycles of 30 seconds of progressive hypoxia to a nadir FIO2 of 8±1% followed by 30 seconds of normoxia. Measurements and Results: The expression of pancreatic UCP-2 mRNA assessed by real-time PCR was 18% lower (P=0.14) in the IH than in the SIH group. Immunohistochemistry identified higher number of beta cells in IH than in SIH group (P=0.14). Glucose levels measured in serum by enzymatic colorimetric methods was lower in IH than in SIH group (P=0.025). Significantly higher serum insulin quantified by ELISA and lower glucagon levels quantified by EIA were seen in the IH group when compared with SIH. Calculations of homeostasis model assessment (HOMA) for insulin resistance suggest higher sensitivity in IH than in SIH mice (P=0.09). HOMA for beta-cell function was higher in IH than in SIH mice (P=0.014). Body weight, adjusted for food intake, was relatively stable during the experiment. No significant differences in lipid profile were encountered. Conclusions: These results suggest that IH causes changes in pancreatic function that may be not related to expression of mRNA UCP2.

京都大学 / 0048 / 新制・課程博士 / 博士(医学) / 甲第18138号 / 医博第3858号 / 新制||医||1002(附属図書館) / 30996 / 京都大学大学院医学研究科医学専攻 / (主査)教授 木村 剛, 教授 坂田 隆造, 教授 羽賀 博典 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

Microparticles produced from kafirin, the sorghum grain prolamin protein, by molecular selfassembly using coacervation with acetic acid solvent are vacuolated. They have shown considerable potential for encapsulation of antioxidants and for preparation of high quality free-standing bioplastic films. However, the functional quality of these kafirin microstructures needs to be improved to exploit their potential application, particularly as biomaterials. Wet heat, transglutaminase and glutaraldehyde treatments were used to modify the physical structure and chemical properties of the kafirin microstructures. Heat treatment (50–96°C) increased microparticle average size by up to four-fold to ≈20 μm, probably due to disulphide cross-linking of kafirin proteins. The vacuoles within these microparticles enlarged up to >10-fold, probably due to greater expansion of air within the microparticles with higher temperature, as the vacuoles are probably footprints of air bubbles. As with heat treatment, glutaraldehyde (10–30%) treatment resulted in oval microparticles, up to about four-fold larger than the control, probably due to covalent glutaraldehyde-polypeptide linkage. Transglutaminase (0.1–0.6%) treatment had only slight effect on the size and shape of microparticles, probably because kafirin has very low lysine content, inhibiting transglutaminase-catalysed cross-linking through ε-(-glutamyl)-lysine bonding. Surface morphology using atomic force microscopy indicated that the microparticles apparently comprised coalesced nanostructures. With heat and transglutaminase treatments, the microparticles seemed to be composed of round nanostructures that coalesced into random irregular shapes, indicative of non-linear protein aggregation. In contrast, with glutaraldehyde treatment, the nanostructures were spindle-shaped and had a unidirectional orientation, probably due to linear alignment of the nanostructures controlled by glutaraldehyde-polypeptide linkage. Thin (<50 μm) films prepared from kafirin microparticles and conventional cast kafirin films were compared in terms of their water stability and other related properties. Films cast from microparticles were more water-stable compared to conventional kafirin films, probably because the large vacuoles within the kafirin microparticles may have enhanced protein solubility in the casting solution, thereby improving the film matrix cohesion. The films prepared from microparticles treated with glutaraldehyde were more water-stable compared to the control, despite the loss of plasticizer, probably due to formation of the covalent glutaraldehyde-polypeptide linkages. The potential of modified kafirin microparticles to bind bone morphogenetic protein-2 (BMP- 2) was investigated. Compared to a collagen standard, the BMP-2 binding capacity of control, heat-treated, transglutaminase-treated and glutaraldehyde-treated kafirin microparticles were 7%, 18%, 34% and 22% higher, respectively, probably mainly due to the vacuoles within the microparticles creating greater binding surface area. The safety, biodegradability and effectiveness of kafirin microparticle film and kafirin microparticle film-BMP-2 system in inducing bone growth were determined by a subcutaneous bioassay using a rat model. Kafirin microparticle film and kafirin microparticle film-BMP-2 system was non-irritant to the animals, probably because kafirin is non-allergenic. The kafirin microparticle film implants showed signs of some degradation but a large proportion of these implants was still intact by Day 28 post implantation, probably because of the low susceptibility of kafirin to mammalian proteolytic enzymes. Kafirin microparticle film-BMP-2 system did not induce bone growth, probably mainly due to low BMP-2 dosage and short study duration. Modification of kafirin microparticles by wet heat or glutaraldehyde treatment both result in increased size of the microparticles with similar gross structure. However, it is apparent that with both treatments the proteins within the pre-formed kafirin microparticles undergo some form of further assisted-assembly through different mechanisms. It seems that heat-induced disulphide cross-linking reinforces a layer around the nanostructures, probably rich in γ- kafirin polypeptides, that stabilizes the structure of the nanostructures. In contrast, glutaraldehyde-treatment appears to destabilize this structure-stabilizing layer through formation of γ-kafirin polypeptide-glutaraldehyde covalent bonding. This probably offsets the balance of attractive and repulsive forces between the different kafirin subclasses within the nanostructures, thereby resulting in collapsed nanostructures and linear realignment. A deeper understanding of the mechanism of kafirin self-assembly will be important for further development of kafirin microstructures for different applications. / Thesis (PhD)--University of Pretoria, 2012. / Food Science / unrestricted

No description available.

Nonhost resistance is a type of broad-spectrum resistance exhibited by a given plant species to most strains of a pathogen which are generally pathogenic to other plant species. In this study, we have examined the role of tobacco SABP2 (Salicylic acid-Binding Protein 2) in nonhost resistance. SABP2, a methyl salicylate esterase is a critical component of SA-signaling pathway in tobacco plants. The transgenic tobacco SABP2-silenced lines treated with tetraFA, a known inhibitor of esterase activity of SABP2 exhibited enhanced susceptibility to nonhost pathogen, Pseudomonas syringae pv. phaseolicola compared to the control plants. The increased accumulation of SABP2 transcripts upon Psp infection supports the involvement of SABP2 in nonhost resistance. The tetra-FA treated plants also showed delayed expression of pathogenesis related-1 gene upon Psp inoculations. The expression of nonhost marker genes CDM1 and HIN1 was also monitored in tobacco plants infected with host-pathogen P.s. pv. tabaci and P.s. pv. phaseolicola. Overall, results presented in this manuscript suggest that SABP2 has a role in nonhost resistance in tobacco plants.